Stockreport

Genmab A/S (GMAB) Discusses 2025 R&D Progress, ASH Data Review, and Strategic Pipeline Additions Transcript [Seeking Alpha]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Jan van de Winkel - Co-Founder, President & CEO Tahamtan Ahmadi - Executive VP, Chief Medical Officer & Head of Experimental Medicines Judith Klimovsky - Executive [Read more]